Scholarlink

<p>Fine-mapping refines genotype–phenotype association signals to identify causal variants underlying complex traits. However, current methods typically focus on individual genomic loci and do not account for the global genetic architecture. Here we demonstrate the advantages of performing genome-wide fine-mapping (GWFM) with functional annotations and develop methods to facilitate GWFM. In simulations and real data analyses, GWFM outperforms current methods across several metrics, including error control, mapping power, resolution, precision, replication rate and <i>trans</i>-ancestry phenotype prediction. Across 48 complex traits, we identify credible sets that collectively explain 18% of the SNP-based heritability <InlineEquation ID="IEq1"> <EquationSource Format="TEX">\(({h}_{\mathrm{SNP}}^{2})\)</EquationSource> <EquationSource Format="MATHML"><math> <mrow> <mo stretchy="true">(</mo> <msubsup> <mrow> <mi>h</mi> </mrow> <mrow> <mi>SNP</mi> </mrow> <mrow> <mn>2</mn> </mrow> </msubsup> <mo stretchy="true">)</mo> </mrow> </math></EquationSource> </InlineEquation> on average, with 30% credible sets located outside genome-wide significant loci. Leveraging the genetic architecture estimated from GWFM, we predict that fine-mapping over 50% of <InlineEquation ID="IEq2"> <EquationSource Format="TEX">\({h}_{\mathrm{SNP}}^{2}\)</EquationSource> <EquationSource Format="MATHML"><math> <msubsup> <mrow> <mi>h</mi> </mrow> <mrow> <mi mathvariant="normal">SNP</mi> </mrow> <mrow> <mn>2</mn> </mrow> </msubsup> </math></EquationSource> </InlineEquation> would require an average of 2 million samples. Finally, as proof-of-principle, we highlight a known causal variant at <i>FTO</i> influencing body mass index and identify new missense causal variants influencing schizophrenia and Crohn’s disease risk.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Genome-wide fine-mapping improves identification of causal variants

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月30日

查看全文
  • Yang Wu,
  • Zhili Zheng,
  • Loic Thibaut,
  • Tian Lin,
  • Qian Feng,
  • Hao Cheng,
  • Loic Yengo,
  • Michael E. Goddard,
  • Naomi R. Wray,
  • Peter M. Visscher,
  • Jian Zeng

摘要

Fine-mapping refines genotype–phenotype association signals to identify causal variants underlying complex traits. However, current methods typically focus on individual genomic loci and do not account for the global genetic architecture. Here we demonstrate the advantages of performing genome-wide fine-mapping (GWFM) with functional annotations and develop methods to facilitate GWFM. In simulations and real data analyses, GWFM outperforms current methods across several metrics, including error control, mapping power, resolution, precision, replication rate and trans-ancestry phenotype prediction. Across 48 complex traits, we identify credible sets that collectively explain 18% of the SNP-based heritability \(({h}_{\mathrm{SNP}}^{2})\) ( h SNP 2 ) on average, with 30% credible sets located outside genome-wide significant loci. Leveraging the genetic architecture estimated from GWFM, we predict that fine-mapping over 50% of \({h}_{\mathrm{SNP}}^{2}\) h SNP 2 would require an average of 2 million samples. Finally, as proof-of-principle, we highlight a known causal variant at FTO influencing body mass index and identify new missense causal variants influencing schizophrenia and Crohn’s disease risk.